Latest chemical biology Stories
BOULDER, Colo. and BOSTON, Oct.
Antibiotic resistance is depleting our arsenal against deadly diseases and infections, such as tuberculosis and Staph infections, but recent research shows promise to speed up the drug discovery process.
Chemists at The Scripps Research Institute (TSRI) have determined the correct structure of a highly promising anticancer compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials in cancer patients.
Informative webinar will provide insight on approaches to phenotypic screening for hit ID in the context of complex and novel biological systems.
A team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex.
Chemists in The College of Arts and Sciences have, for the first time, created enzyme-like activity using peptides that are only seven amino acids long.
Joint Publication Identifies Clinical Kinase Inhibitors that Potently Cross React with Bromodomain Epigenetic Reader Proteins OXFORD, United Kingdom and FREMONT, Calif., March 5, 2014
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence
Lab on a Chip is a peer-reviewed scientific journal published bi-weekly (24 issues per year) by the Royal Society of Chemistry (RSC). It was established in 2001 and hosts RSC’s other publications: Highlights in Chemical Technology and Highlights in Chemical Biology. The editor-in-chief is Harp Minhas. Lab on a Chip publishes original primary research and review articles on any aspect of miniaturization at the micro and nano scale. It covers a variety of disciplines including chemistry,...
- The act of sweetening by admixture of some saccharine substance.